Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma — Stella

Home/Neuroblastoma/

View on ClinicalTrials.gov

Recruiting

Back to Neuroblastoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Netherlands

Princess Maxima center for pediatric oncology, Utrecht, Utrecht

Key details

Phase

Early testing

Sponsor

Princess Maxima Center for Pediatric Oncology

Collaborators

EUSA Pharma, Inc.

Enrollment target

~38 participants

Started

January 2025

Primary completion

July 2030

Age range

18 Months – 18 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.